{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:51:10Z","timestamp":1793454670396,"version":"4.5.0"},"reference-count":111,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,11,23]]},"DOI":"10.1001\/jama.2021.17633","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:12:09Z","timestamp":1637687529000},"page":"2055","source":"Crossref","is-referenced-by-count":381,"title":["Management of Acne Vulgaris"],"prefix":"10.1001","volume":"326","author":[{"given":"Dawn Z.","family":"Eichenfield","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of California San Diego School of Medicine, La Jolla"},{"name":"Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sprague","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Diego School of Medicine, La Jolla"},{"name":"Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Diego School of Medicine, La Jolla"},{"name":"Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California"},{"name":"Department of Pediatrics, University of California San Diego School of Medicine, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jrv210014r1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.2015.172.issue-S1","article-title":"A global perspective on the epidemiology of acne.","volume":"172","author":"Tan","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"jrv210014r2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.2013.168.issue-3","article-title":"Epidemiology of acne vulgaris.","volume":"168","author":"Bhate","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"jrv210014r3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjd.v184.2","article-title":"Reviewing the global burden of acne: how could we improve care to reduce the burden?","volume":"184","author":"Layton","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"jrv210014r4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2133.1997.tb08748.x","article-title":"Post-adolescent acne: a review of clinical features.","volume":"136","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"issue":"3","key":"jrv210014r5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/ced.12270","article-title":"What\u2019s new in acne? an analysis of systematic reviews published in 2011-2012.","volume":"39","author":"Bhate","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"jrv210014r6","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","article-title":"Evidence-based recommendations for the diagnosis and treatment of pediatric acne.","volume":"131","author":"Eichenfield","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"jrv210014r7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris.","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"jrv210014r8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40168-018-0558-5","article-title":"Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.","volume":"6","author":"O\u2019Neill","year":"2018","journal-title":"Microbiome"},{"key":"jrv210014r9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jsbmb.2014.06.004","article-title":"Premature adrenarche: etiology, clinical findings, and consequences.","volume":"145","author":"Voutilainen","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"jrv210014r10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.clinbiochem.2011.06.984","article-title":"Role of hormones in acne vulgaris.","volume":"44","author":"Arora","year":"2011","journal-title":"Clin Biochem"},{"issue":"3","key":"jrv210014r11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/1523-1747.ep12874121","article-title":"Androgen excess in women with acne alone compared with women with acne and\/or hirsutism.","volume":"94","author":"Vexiau","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"2","key":"jrv210014r12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"jrv210014r13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome.","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"jrv210014r14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bjd.v185.3","article-title":"The need for comparative effectiveness data to guide management of acne vulgaris.","volume":"185","author":"Barbieri","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"jrv210014r15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clindermatol.2016.10.007","article-title":"Drug-induced acne.","volume":"35","author":"Kazandjieva","year":"2017","journal-title":"Clin Dermatol"},{"issue":"7","key":"jrv210014r16","first-page":"40","article-title":"A Comprehensive critique and review of published measures of acne severity.","volume":"9","author":"Agnew","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"jrv210014r17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/09546634.2018.1442552","article-title":"Clinical evidence for washing and cleansers in acne vulgaris: a systematic review.","volume":"29","author":"Stringer","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"jrv210014r18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bjd.v185.3","article-title":"Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.","volume":"185","author":"Stuart","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"jrv210014r19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","article-title":"Topical retinoids in acne vulgaris: a systematic review.","volume":"20","author":"Kolli","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"jrv210014r20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/ada.2019.87443","article-title":"Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments.","volume":"36","author":"Zasada","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"jrv210014r21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1525-1470.2008.00688.x","article-title":"Adapalene gel 0.1% in the treatment of infantile acne: an open clinical study.","volume":"25","author":"Kose","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"jrv210014r22","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1542\/peds.2009-3447","article-title":"Study of the efficacy and tolerability of 0.04% tretinoin microsphere gel for preadolescent acne.","volume":"125","author":"Eichenfield","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"jrv210014r23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1684\/ejd.2018.3367","article-title":"The safety and efficacy of four different fixed combination regimens of adapalene 0.1%\/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.","volume":"28","author":"Tan","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"1","key":"jrv210014r24","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14724","article-title":"Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: a randomized, controlled, assessor-blinded two-center trial: the MASCOTTE study.","volume":"34","author":"Bertolani","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"jrv210014r25","first-page":"WC04","article-title":"Tretinoin nanogel 0.025% versus conventional gel 0.025% in patients with acne vulgaris: a randomized, active controlled, multicentre, parallel group, phase iv clinical trial.","volume":"9","author":"Chandrashekhar","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"jrv210014r26","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1542\/peds.2005-2022","article-title":"Expert committee recommendations for acne management.","volume":"118","author":"Zaenglein","year":"2006","journal-title":"Pediatrics"},{"key":"jrv210014r27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.","volume":"139","author":"Grosshans","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3","key":"jrv210014r28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3%\/benzoyl peroxide 2.5% gel: a randomized, double-blind, parallel-group, controlled study.","volume":"17","author":"Stein Gold","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"jrv210014r29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2004.10.879","article-title":"Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.","volume":"54","author":"Thiboutot","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"jrv210014r30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","article-title":"Randomized phase 3 evaluation of trifarotene 50 \u00b5g\/g cream treatment of moderate facial and truncal acne.","volume":"80","author":"Tan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8854","key":"jrv210014r31","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/0140-6736(93)91004-6","article-title":"First trimester topical tretinoin and congenital disorders.","volume":"341","author":"Jick","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"jrv210014r32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bjd.1994.130.issue-5","article-title":"Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin.","volume":"130","author":"Hegemann","year":"1994","journal-title":"Br J Dermatol"},{"issue":"5","key":"jrv210014r33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/09546634.2012.699179","article-title":"A systematic review of benzoyl peroxide for acne vulgaris.","volume":"24","author":"Mohd Nor","year":"2013","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"jrv210014r34","first-page":"417","article-title":"Antibiotic-resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.","volume":"82","author":"Leyden","year":"2008","journal-title":"Cutis"},{"issue":"4","key":"jrv210014r35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.18231\/j.ijced.2019.064","article-title":"A comparative study of acne vulgaris with special reference to therapeutic options.","volume":"5","author":"Kumar","year":"2019","journal-title":"IP Indian J Clin and Exp Dermatol."},{"key":"jrv210014r36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1525-1470.2008.00667.x","article-title":"Practical considerations in acne treatment and the clinical impact of topical combination therapy.","volume":"25","author":"Krakowski","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"jrv210014r37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/cia2.v2.4","article-title":"Twenty cases of allergic contact dermatitis due to benzoyl peroxide in acne patients in Japan.","volume":"2","author":"Iijima","year":"2019","journal-title":"J Cutan Immunol Allergy."},{"issue":"1","key":"jrv210014r38","article-title":"Topical antibiotics for acne.","volume":"2018","author":"Lazic Mosler","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jrv210014r39","first-page":"655","article-title":"The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.","volume":"9","author":"Patel","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"jrv210014r40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaad.2019.05.078","article-title":"Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: a phase 3 study.","volume":"82","author":"Raoof","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"jrv210014r41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2018.08.020","article-title":"A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: results of 2 randomized, double-blind, phase 3 studies.","volume":"80","author":"Gold","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"jrv210014r42","first-page":"427","article-title":"The use of sulfur in dermatology.","volume":"3","author":"Gupta","year":"2004","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"jrv210014r43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00128071-200910040-00002","article-title":"Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.","volume":"10","author":"Stotland","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"jrv210014r44","doi-asserted-by":"publisher","first-page":"439.e1","DOI":"10.1016\/j.jaad.2006.10.005","article-title":"Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.","volume":"56","author":"Draelos","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"jrv210014r45","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1001\/archdermatol.2008.518","article-title":"Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.","volume":"144","author":"Piette","year":"2008","journal-title":"Arch Dermatol"},{"issue":"9","key":"jrv210014r46","first-page":"964","article-title":"Azelaic acid: evidence-based update on mechanism of action and clinical application.","volume":"14","author":"Schulte","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"jrv210014r47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"jrv210014r48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bjd.2011.165.issue-1","article-title":"Cortexolone 17a-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris: a pilot randomized, double-blind comparative study vs placebo and tretinoin 0\u00b705% cream.","volume":"165","author":"Trifu","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11","key":"jrv210014r49","first-page":"1395","article-title":"Treatment of 2453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.","volume":"9","author":"Eichenfield","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"jrv210014r50","first-page":"103","article-title":"Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.","volume":"86","author":"Yentzer","year":"2010","journal-title":"Cutis"},{"issue":"3","key":"jrv210014r51","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013.","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"jrv210014r52","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): a retrospective cohort study.","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"jrv210014r53","first-page":"619","article-title":"A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.","volume":"12","author":"Zaenglein","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"jrv210014r54","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/j.1365-2133.2011.10344.x","article-title":"A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.","volume":"164","author":"Poulin","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"jrv210014r55","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archderm.142.5.597","article-title":"Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.","volume":"142","author":"Thiboutot","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"jrv210014r56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01297-18","article-title":"Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris.","volume":"63","author":"Zhanel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"jrv210014r57","first-page":"40","article-title":"Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives.","volume":"4","author":"Leyden","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"jrv210014r58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/09546639609089553","article-title":"The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans.","volume":"7","author":"Leyden","year":"1996","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"jrv210014r59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1442-2050.2004.00384.x","article-title":"Doxycycline-induced pill esophagitis.","volume":"17","author":"Kadayifci","year":"2004","journal-title":"Dis Esophagus"},{"issue":"6","key":"jrv210014r60","first-page":"281","article-title":"Double blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers.","volume":"4","author":"Bjellerup","year":"1987","journal-title":"Photodermatol"},{"issue":"11","key":"jrv210014r61","first-page":"E53","article-title":"Safety and tolerability of sarecycline for the treatment of acne vulgaris: results from a phase III, multicenter, open-label study and a phase I phototoxicity study.","volume":"12","author":"Pariser","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"jrv210014r62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5694\/mja2.1998.169.issue-5","article-title":"Systematic review of propionibacterium acnes resistance to systemic antibiotics.","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aust"},{"issue":"9","key":"jrv210014r63","first-page":"26","article-title":"Oral antibiotic treatment options for acne vulgaris.","volume":"13","author":"Baldwin","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"jrv210014r64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"3","key":"jrv210014r65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris.","volume":"71","author":"Koo","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"jrv210014r66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"US medical eligibility criteria for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"jrv210014r67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cen.2019.90.issue-4","article-title":"Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies.","volume":"90","author":"Goshtasebi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"jrv210014r68","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050756","article-title":"Spironolactone and XPB: an old drug with a new molecular target.","volume":"10","author":"Gabbard","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"jrv210014r69","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne.","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"jrv210014r70","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jaad.2020.12.071","article-title":"Long-term use of spironolactone for acne in women: a case series of 403 patients.","volume":"84","author":"Garg","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"jrv210014r71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40257-020-00511-5","article-title":"Oral spironolactone for acne vulgaris in adult females: an update of the literature.","volume":"21","author":"Barker","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"jrv210014r72","first-page":"632","article-title":"Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016.","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"jrv210014r73","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne.","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"jrv210014r74","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamadermatol.2020.5468","article-title":"Temporal trends and clinician variability in potassium monitoring of healthy young women treated for acne with spironolactone.","volume":"157","author":"Barbieri","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"jrv210014r75","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaad.2018.10.023","article-title":"Lack of evidence for feminization of males exposed to spironolactone in utero: a systematic review.","volume":"80","author":"Liszewski","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"jrv210014r76","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.canep.2013.10.004","article-title":"Spironolactone use and the risk of breast and gynecologic cancers.","volume":"37","author":"Biggar","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"jrv210014r77","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.","volume":"83","author":"Mackenzie","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"jrv210014r78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1203475415595776","article-title":"Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150 mg\/kg.","volume":"20","author":"Tan","year":"2016","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"jrv210014r79","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/ijd.2016.55.issue-5","article-title":"Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris.","volume":"55","author":"Rademaker","year":"2016","journal-title":"Int J Dermatol"},{"issue":"4","key":"jrv210014r80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ijd.v60.4","article-title":"Isotretinoin in the management of acne vulgaris: practical prescribing.","volume":"60","author":"Fallah","year":"2021","journal-title":"Int J Dermatol"},{"issue":"12","key":"jrv210014r81","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"9","key":"jrv210014r82","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archderm.143.9.1187","article-title":"What is the chance of a normal pregnancy in a woman whose fetus has been exposed to isotretinoin?","volume":"143","author":"Sladden","year":"2007","journal-title":"Arch Dermatol"},{"issue":"3","key":"jrv210014r83","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaad.2010.06.040","article-title":"Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel \u201cpatient symptom survey\u201d approach.","volume":"65","author":"Hodgkiss-Harlow","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"jrv210014r84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jaad.2016.03.019","article-title":"Standardized laboratory monitoring with use of isotretinoin in acne.","volume":"75","author":"Hansen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"jrv210014r85","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","article-title":"A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"jrv210014r86","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/bjd.15207","article-title":"Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.","volume":"177","author":"Opel","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"jrv210014r87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaad.2019.06.025","article-title":"The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.","volume":"82","author":"Barbieri","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"jrv210014r88","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/ajd.2010.51.issue-4","article-title":"Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin.","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"2","key":"jrv210014r89","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study.","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"14","key":"jrv210014r90","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","article-title":"Acne vulgaris.","volume":"379","author":"Zaenglein","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"jrv210014r91","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamadermatol.2019.1416","article-title":"Psychiatric adverse events in patients taking isotretinoin as reported in a Food and Drug Administration database from 1997 to 2017.","volume":"155","author":"Singer","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"jrv210014r92","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/ije\/dyz093","article-title":"Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study.","volume":"48","author":"Droitcourt","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"2","key":"jrv210014r93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data.","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"jrv210014r94","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MEG.0000000000000496","article-title":"Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? a meta-analysis.","volume":"28","author":"Lee","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"jrv210014r95","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"jrv210014r96","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaad.2020.07.041","article-title":"Isotretinoin and risk of inflammatory bowel disease: more data to support lack of meaningful risk.","volume":"84","author":"Barbieri","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"jrv210014r97","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaad.2009.07.043","article-title":"Diet and acne.","volume":"63","author":"Bowe","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"jrv210014r98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ajcn\/86.1.107","article-title":"A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial.","volume":"86","author":"Smith","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"jrv210014r99","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/jdv.2018.32.issue-12","article-title":"The effect of milk consumption on acne: a meta-analysis of observational studies.","volume":"32","author":"Dai","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"jrv210014r100","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/jamadermatol.2020.1602","article-title":"Association between adult acne and dietary behaviors: findings from the nutrinet-sant\u00e9 prospective cohort study.","volume":"156","author":"Penso","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"jrv210014r101","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/DSS.0000000000000715","article-title":"Energy-based devices in treatment of acne vulgaris.","volume":"42","author":"Handler","year":"2016","journal-title":"Dermatol Surg"},{"issue":"1","key":"jrv210014r102","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jocd.v19.1","article-title":"Efficacy of photodynamic therapy for the treatment of inflammatory acne vulgaris: a systematic review and meta-analysis.","volume":"19","author":"Tang","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"jrv210014r103","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/archderm.1983.01650300034012","article-title":"Intralesional corticosteroids in the treatment of nodulocystic acne.","volume":"119","author":"Levine","year":"1983","journal-title":"Arch Dermatol"},{"issue":"2","key":"jrv210014r104","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40257-018-0352-y","article-title":"Prevention and reduction of atrophic acne scars with adapalene 0.3%\/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison.","volume":"19","author":"Dr\u00e9no","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"jrv210014r105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bjd.2018.178.issue-1","article-title":"Light therapies for acne: abridged Cochrane systematic review including GRADE assessments.","volume":"178","author":"Barbaric","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"jrv210014r106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijwd.2017.10.006","article-title":"A review of diagnosis and treatment of acne in adult female patients.","volume":"4","author":"Tan","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"jrv210014r107","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijwd.2018.03.006","article-title":"Safety and effectiveness of amoxicillin in the treatment of inflammatory acne.","volume":"4","author":"Guzman","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"jrv210014r108","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/dth.2013.26.issue-4","article-title":"Treatment of acne vulgaris in pregnant patients.","volume":"26","author":"Pugashetti","year":"2013","journal-title":"Dermatol Ther"},{"issue":"7","key":"jrv210014r109","first-page":"19","article-title":"Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne.","volume":"7","author":"Callender","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"jrv210014r110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40257-013-0049-1","article-title":"Acne in patients with skin of color: practical management.","volume":"15","author":"Yin","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"jrv210014r111","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaad.2016.11.028","article-title":"Evidence-based recommendations for the management of acne fulminans and its variants.","volume":"77","author":"Greywal","year":"2017","journal-title":"J Am Acad Dermatol"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2786495\/jama_eichenfield_2021_rv_210014_1637351900.70522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:12:51Z","timestamp":1637687571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2786495"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":111,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,11,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.17633","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}